NDC 53808-0777

Renagel

Renagel

Renagel is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Doh Central Pharmacy. The primary component is Sevelamer Hydrochloride.

Product ID53808-0777_5ec67fac-794f-4ca5-a5ef-6a0cf51565e0
NDC53808-0777
Product TypeHuman Prescription Drug
Proprietary NameRenagel
Generic NameRenagel
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2009-07-01
Marketing CategoryNDA / NDA
Application NumberNDA021179
Labeler NameDOH CENTRAL PHARMACY
Substance NameSEVELAMER HYDROCHLORIDE
Active Ingredient Strength800 mg/1
Pharm ClassesPhosphate Binder [EPC],Phosphate Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 53808-0777-1

30 TABLET in 1 BLISTER PACK (53808-0777-1)
Marketing Start Date2009-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53808-0777-1 [53808077701]

Renagel TABLET
Marketing CategoryNDA
Application NumberNDA021179
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-07-01
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
SEVELAMER HYDROCHLORIDE800 mg/1

OpenFDA Data

SPL SET ID:4a3b3dd8-9b4a-4a00-8178-eb8417195081
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 857224
  • UPC Code
  • 0358468002112
  • Pharmacological Class

    • Phosphate Binder [EPC]
    • Phosphate Chelating Activity [MoA]

    NDC Crossover Matching brand name "Renagel" or generic name "Renagel"

    NDCBrand NameGeneric Name
    17856-0021RenagelRenagel
    53808-0777RenagelRenagel
    58468-0020RenagelRenagel
    58468-0021Renagelsevelamer hydrochloride
    67544-656RenagelRenagel
    68151-4295RENAGELRenagel

    Trademark Results [Renagel]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    RENAGEL
    RENAGEL
    74590044 1978935 Live/Registered
    GENZYME CORPORATION
    1994-10-24

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.